Adolescent Medicine

Alcohol Abuse

Allergies and Infant Formula

Allergy, Immunology, and ENT

Animal Allergies

Autism

Cardiology

Dermatology

Developmental/Behavioral Disorders

Drug Pipeline News

Emergency Medicine

Endocrinology

Gastroenterology

Gynecology

Infectious disease

Mental Health

Neurology

Nutrition

Nutrition News

Obstetrics-Gynecology & Women's Health

Oncology

Pain

Practice Improvement

Psychiatry

Respiratory

Rheumatoid Arthritis

Sexual Health

Skin Diseases

Telemedicine

News 

All News

PNP Corner

AAP Guidelines

Media

Around the Practice

Cure Connections

Expert Interviews

Insights

Medical World News

Peer Exchange

Peers & Perspectives

Podcasts

Webinars

Puzzler

Publications

Contemporary Pediatrics Journal

Supplements And Featured Publications

CME/CE

Resources

Handouts

Job Board

Conferences

Partnerships

Subscribe

Print Subscription

eNewsletter

Articles

In a recent study, reductions in body mass index along with further beneficial effects were found when using oral butyrate supplementation for treating pediatric obesity.

Butyrate effective for treating pediatric obesity

At the 44th National Association of Pediatric Nurse Practitioners Conference, drug products abused by teenagers were discussed.

Which drug products are abused by adolescents?

At the 44th National Association of Pediatric Nurse Practitioners Conference, methods of treating atopic dermatitis were discussed.

Treating pediatric atopic dermatitis

At the 44th National Association of Pediatric Nurse Practitioners Conference, pediatric aggression was discussed, including which patients are at greater risk and which management strategies are most appropriate.

Managing aggression in pediatric patients

About Us

Advertise

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Contemporary Pediatrics

Facebook

Twitter

LinkedIn

Instagram

Spotlight

2022 Best Tech

Contemporary Pediatrics® Resident Writer Program

Demystifying Infant Formula

Do we take RSV disease seriously enough?

Food Insecurity and the Dangers of Infant Formula Dilution

Getting into the Roots of Childhood Atopic Dermatitis

Opt-Out Chlamydia Screening in Adolescent Care

The Role of the Healthcare Provider Community in Increasing Public Awareness of RSV in All Infants

Update in Pediatric COVID-19 Vaccines

Clinical

View More

1rem

Authors

Janssen, a pharmaceutical subsidiary of Johnson & Johnson, has announced plans to pursue a pediatric indication for its best-selling blood thinner, Xarelto (rivaroxaban).

New Phase 3 data advances pursuit of pediatric indication for Xarelto

Teresa McNulty

Articles